3.925
9.80%
0.3503
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News
Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Evaluating the Annual Growth - The News Heater
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart
Scinai Regains Full Compliance with Nasdaq Listing Requirements - Benzinga
Scinai secures $2 million investment commitment By Investing.com - Investing.com India
Scinai reports promising psoriasis treatment study - Investing.com
Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):